B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities

B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities — Trials · CancerIndex

Clinical trials

Registered studies

46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04501614	A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	terminated	Phase 1 / Phase 2	11	TakedaINDUSTRY	15	Oct 2, 2025	clinicaltrials
NCT02420717	Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia	terminated	Phase 2	11	M.D. Anderson Cancer CenterOTHER	1	Jun 8, 2025